首页> Gynecologic oncology reports> Recurrent uterine inflammatory myofibroblastic tumor previously managed as leiomyosarcoma has sustained response to alectinib.

Recurrent uterine inflammatory myofibroblastic tumor previously managed as leiomyosarcoma has sustained response to alectinib.

导出 LinkOut

翻译打印收藏纠错

第一作者： Erica V,Carballo

第一单位： Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Emory University School of Medicine, United States.

作者： Erica V,Carballo ^[1] ; Tra V,Pham ^[1] ; Gulisa,Turashvili ^[2] ; Krisztina,Hanley ^[2] ; Kristen D,Starbuck ^[1] ; Jane L,Meisel ^[3]

作者单位： Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Emory University School of Medicine, United States. ^[1] Department of Pathology and Laboratory Medicine, Emory University School of Medicine, United States. ^[2] Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Emory University School of Medicine, United States.;Division of Medical Oncology, Department of Hematology and Medical Oncology, Emory University School of Medicine, United States. ^[3]

关键词 ALK fusion ALK-inhibitor Case report TNS1-ALK fusion Uterine inflammatory myofibroblastic tumor Uterine leiomyosarcoma

DOI 10.1016/j.gore.2022.101062

PMID 36032811

发布时间 2024-09-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Gynecologic oncology reports

2022年43卷

101062页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览2

点击下载本期目录封面

Gynecologic oncology reports

2022年43卷

101062页

检索历史清除

Recurrent uterine inflammatory myofibroblastic tumor previously managed as leiomyosarcoma has sustained response to alectinib.

Gynecologic oncology reports

相似文献

同项目论文

Gynecologic oncology reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Recurrent uterine inflammatory myofibroblastic tumor previously managed as leiomyosarcoma has sustained response to alectinib.

Gynecologic oncology reports

相似文献

同项目论文

Gynecologic oncology reports

相关期刊

检索历史清除